Edition:
India

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

23.14CAD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$23.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,145,276
52-wk High
$30.56
52-wk Low
$11.20

Chart for

About

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment,... (more)

Overall

Beta: -0.36
Market Cap(Mil.): $5,024.01
Shares Outstanding(Mil.): 347.33
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.91 10.66
ROE: -- 16.41 14.30

BRIEF-Ortho Dermatologics Says U.S. FDA Filing Acceptance For Jemdel Plaque Psoriasis Treatment

Feb 14 Valeant Pharmaceuticals International Inc :

14 Feb 2018

BRIEF-Salix Provides Update On FDA Submission For Plenvu

Feb 9 Valeant Pharmaceuticals International Inc :

09 Feb 2018

BRIEF-Valeant To Reduce Debt By An Additional $200 Million

Jan 25 Valeant Pharmaceuticals International Inc :

26 Jan 2018

CANADA STOCKS-TSX slips as financials, Valeant and CN Rail weigh

* TSX closes down 73.34 points, or 0.45 percent, at 16,284.21

25 Jan 2018

CANADA STOCKS-TSX falls as Valeant, CN Rail and financials weigh

TORONTO, Jan 24 Canada's main stock fell on Wednesday, weighed by declines for financial shares, Valeant Pharmaceuticals International Inc and Canadian National Railway Co, while gold mining stocks were boosted by higher gold prices.

25 Jan 2018

BRIEF-Valeant Pays Down $300 Million Of Senior Secured Term Loans

Jan 3 Valeant Pharmaceuticals International Inc :

03 Jan 2018

UPDATE 1-Pershing Square, Valeant to appear in court on insider trading suit settlement

Jan 2 A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

03 Jan 2018

Pershing Square, Valeant asked to appear for hearing on insider trading suit

Jan 2 A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

03 Jan 2018

Earnings vs. Estimates